Form 4 for AMLX Amylyx Pharmaceuticals, Inc.
Accepted 2024-01-18 00:00:00 ET · period of report 2024-01-16 · accession 0000950170-24-005437 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-01-18 | 2024-01-16 | AMLX | MILNE GEORGE M JR | Dir | G - Gift | $0.00 | -94.3K | 767.7K | -11% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-01-16 | G | D | 94,350 | $0.00 | 767,671 | D | — | — |